Literature DB >> 803545

Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction.

H M Wisniewski, B R Bloom.   

Abstract

Primary demyelination occurs in a variety of human and experimental diseases known to be associated with the presence of inflammatory cells. However, the mechanism of demyelination remains unclear. The possibility that myelin can be damaged as a nonspecific consequence of a specific delayed type of hypersensitivity reaction directed at nonnervous tissue antigens was investigated. Guinea pigs were sensitized to tuberculin with Freund's complete adjuvant, and were challenged in the central and peripheral nervous system either with live or killed sonicated tubercle bacilli, Old Tuberculin, or tuberculin purified protein derivative (PPD). Local inflammatory reactions were invariably produced and primary demyelination was a constant feature of the lesions. The morphological picture was rather similar to that observed in human neurotuberculosis and early tuberculoid leprosy, and in experimental allergic encephalomyelitis and distemper encephalitis in animals. The infiltrates consisted predominantly of mononuclear cells with some polymorphonuclear cells as well. Vesicular disruption of the myelin sheath in the immediate vicinity of the inflammatory cells and stripping of the myelin lamellae by the histiocytes without axonal damage were the leading features of the lesion. The results indicate that cell-mediated immune reactions to a variety of nonbrain antigens could be responsible for a component of the demyelination seen in some inflammatory demyelinating conditions, and suggest that this system may serve as a useful model for studying the immunopathology of demyelinating disease.

Entities:  

Mesh:

Year:  1975        PMID: 803545      PMCID: PMC2190530          DOI: 10.1084/jem.141.2.346

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Mycobacterium leprae in nerve lesions in lepromatous leprosy. An electron microscopic study.

Authors:  C K Job
Journal:  Arch Pathol       Date:  1970-03

2.  Cell-mediated demyelination of peripheral nerve in tissue culture.

Authors:  B G Arnason; G F Winkler; N M Hadler
Journal:  Lab Invest       Date:  1969-07       Impact factor: 5.662

3.  Light and electron microscopy observations on the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis).

Authors:  R M Herndon; L J Rubinstein
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

Review 4.  Association of papova-virions with a human demyelinating disease (progressive multifocal leukoencephalopathy).

Authors:  G M Zu Rhein
Journal:  Prog Med Virol       Date:  1969

5.  Observations on viral demyelinating encephalomyelitis. Canine distemper.

Authors:  H Wiśniewski; C S Raine; W J Kay
Journal:  Lab Invest       Date:  1972-05       Impact factor: 5.662

6.  Experimental allergic encephalomyelitis: demyelinating activity of serum and sensitized lymph node cells on cultured nerve tissues.

Authors:  M B Bornstein; H Iwanami
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

7.  The pathology and pathogenesis of tuberculous encephalopathy.

Authors:  D K Dastur; P M Udani
Journal:  Acta Neuropathol       Date:  1966-07-07       Impact factor: 17.088

8.  Spinal meningitides with radiculo-myelopathy. 2. Pathology and pathogenesis.

Authors:  D Dastur; N H Wadia
Journal:  J Neurol Sci       Date:  1969 Mar-Apr       Impact factor: 3.181

9.  An ultrastructural study of experimental demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral nervous system.

Authors:  H Wiśniewski; J Prineas; C S Raine
Journal:  Lab Invest       Date:  1969-08       Impact factor: 5.662

10.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS.

Authors:  T M Rivers; F F Schwentker
Journal:  J Exp Med       Date:  1935-04-30       Impact factor: 14.307

View more
  60 in total

1.  Pathogenesis of multiple sclerosis.

Authors:  R A Hughes
Journal:  J R Soc Med       Date:  1992-07       Impact factor: 5.344

2.  A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts of the central nervous system.

Authors:  K Huang; J S Geoffroy; M S Singer; S D Rosen
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 3.  Mechanisms of immune-mediated demyelinating disease of the central nervous system.

Authors:  D Baker; A N Davison
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 4.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

5.  T lymphocyte autoimmunity in peripheral nervous system autoimmune disease.

Authors:  C Linington; H Wekerle; R Meyermann
Journal:  Agents Actions       Date:  1986-12

Review 6.  Neurosurgically relevant aspects of pathology and pathogenesis of intracranial and intraspinal tuberculosis.

Authors:  D K Dastur
Journal:  Neurosurg Rev       Date:  1983       Impact factor: 3.042

7.  Herpes simplex virus infection and damage in the central nervous system: immunomodulation with adjuvant, cyclophosphamide and cyclosporin A.

Authors:  S A Bishop; T J Hill
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  The significance of perivascular infiltrations in multiple sclerosis.

Authors:  A Guseo; K Jellinger
Journal:  J Neurol       Date:  1975-12-02       Impact factor: 4.849

9.  Cell-mediated cytotoxicity against murine cells infected with 6/94 virus, a parainfluenza type 1 isolate from multiple sclerosis brain tissue.

Authors:  L J Lewandowski; W U Gerhard; J C Palmer
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

Review 10.  Oligodendrocytes: biology and pathology.

Authors:  Monika Bradl; Hans Lassmann
Journal:  Acta Neuropathol       Date:  2009-10-22       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.